Products
Renew
Claim
Support
Become an Agent
Wellness Blog
29 Jul 2026
Bajaj General Insurance

666 Viewed
In chronic myeloid leukaemia (CML), the bone marrow produces abnormal granulocytes, which are a subset of white blood cells. Typical symptoms of CML are breathing difficulties or dyspnoea, weakness or exhaustion, fever, and so on. The primary methods for diagnosing CML are a bone marrow biopsy and a blood test.
Moreover, healthcare professionals classify CML into one of four stages. Continue reading to know what is CML in more detail, including its risk factors and treatments.
Chronic myeloid leukaemia (CML) is a type of chronic leukaemia which often worsens gradually. The bone marrow produces aberrant granulocytes, a subset of white blood cells, in CML. Another name for these aberrant cells is blasts. Anaemia, easy bleeding, and infection might result from the aberrant cells pushing out the healthy cells.
Additionally, the aberrant cells may go to other areas of the body outside of the blood. Adults with CML typically get the disease at or after middle age. In youngsters, it is uncommon.
It is possible to have CML without experiencing any symptoms. The modest signs of chronic myeloid leukaemia worsen with time. Typical signs of CML might be:
1. Breathing difficulties or dyspnoea
2. Fever
3. Weakness or exhaustion
4. Weight loss without any reason
5. Soreness or swelling in the upper left portion of your abdomen, which is where your spleen is located
6. Feeling full after a small meal
7. Sweats during the night
Also Read: What Are the Main Types of Cancer?
A genetic alteration known as the Philadelphia chromosome is present in the majority of CML patients. It was found by researchers in Philadelphia, which is why it has that name.
Each human cell typically has 23 pairs of chromosomes. Your DNA, or genetic material, is found on these chromosomes. A portion of one chromosome's DNA shifts to another chromosome in CML. There, it joins forces with certain DNA to form a new gene known as BCR-ABL.
Your bone marrow produces an aberrant protein as a result of this gene. The leukaemia cells can proliferate uncontrollably because of this protein.
Parents do not pass down the Philadelphia chromosome to their offspring. It takes place in your lifetime. The reason is unknown.
A bone marrow biopsy and a blood test are the two primary methods used to diagnose CML. A lab receives a blood sample, which is examined under a microscope. A bone marrow biopsy, which involves sending a sample of your bone marrow to a laboratory for microscopic examination.
In addition to determining if the bone marrow cells include the Philadelphia chromosome or the BCR-ABL gene, the physician will be able to examine the type of cells present and the quantity of cells being generated.
Chronic myeloid leukaemia might require long-term therapy and continuous medical costs. Bajaj General Medical Insurance offers the Criti Care plan to help you handle the financial burden of covered critical diseases while you focus on your recovery.
Healthcare professionals do not classify chronic myeloid leukaemia according to disease stages, in contrast to many other forms of cancer. They classify CML into one of four stages:
In CML, ‘chronic’ means the percentage of blasts, or immature white blood cells, in your bone marrow and blood. About 10% of the cells in your blood and bone marrow are blasts in chronic CML. Chronic CML affects 80% to 90% of those with the diagnosis. People with chronic CML may or may not exhibit symptoms.
During this CML phase, 10% to 19% of the cells in your bone marrow or blood are blasts. Additionally, providers could search for basophils. White blood cells called basophils produce enzymes to enhance blood flow and stop blood clots. You may have higher basophil counts if you have CML.
Blast CML can be fatal. Tests for blast CML reveal that at least 20% of the cells in your bone marrow or blood are blasts. Extreme exhaustion, fever, weight loss, and dyspnoea are common symptoms of blast phase CML.
Resistant CML is CML that either does not respond to treatment or returns after treatment.
The following factors raise the chance of developing chronic myeloid leukaemia:
1. Older Age: Compared to toddlers and teenagers, older adults are more likely to have CML.
2. Exposure to Radiation: CML has been connected to radiation treatment for several cancer types.
Also Read: Chemotherapy: How It Works, Side Effects, and Treatment Options
Chronic myeloid leukaemia is a cancer of the blood and bone marrow. CML may become a chronic condition as a result of breakthrough therapies that place some kinds of CML in long-term remission. The therapies you receive will be determined by your phase, age, overall health, and other considerations.
Consider a Criti Care plan from Bajaj General Insurance to help protect yourself from unforeseen medical bills and provide access to quality treatment when necessary.
CML and CLL are two types of leukaemia that originate in the blood or bone marrow. The distinction is that CML originates in myeloid stem cells, while CLL originates in lymphoid stem cells.
Survival rates for myeloid leukaemia vary greatly depending on whether it is acute (AML) or chronic (CML), with age and genetic variables also playing important roles.
With targeted therapy such as TKIs, the 5-year relative survival rate for CML is greater than 90%.
CML is treatable with new targeted medicines; most patients have profound, long-term remissions and may live a normal life.
Some of the early signs of CML are fatigue or weakness, mild fever, pale skin, or lingering infections.
Disclaimer: The content on this page is generic and shared only for informational and explanatory purposes. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making any related decisions.
Insurance is the subject matter of solicitation. For more details on benefits, exclusions, limitations, terms, and conditions, please read the sales brochure/policy wording carefully before concluding a sale.
With GST waiver, individual and family floater policies for health, personal accident, and travel insurance (on retail basis) are 18% cheaper from 22 September 2025. Secure what matters at an affordable price!
